Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Yates, Tom; Davies, Melanie J; Jung, Hyejung; Bosch, Jackie; Spinas, Giatgen A; Sreenan, Seamus; Commerford, Patrick; Gerstein, Hertzel C; ORGIN investigators (2017). Effect of insulin glargine on recreational physical activity and TV viewing: Analysis of the randomised ORIGIN trial. Diabetes Research and Clinical Practice, 132:137-143.

Pfeffer, Marc A; Claggett, Brian; Diaz, Rafael; Dickstein, Kenneth; Gerstein, Hertzel C; Køber, Lars V; Lawson, Francesca C; Ping, Lin; Wei, Xiaodan; Lewis, Eldrin F; Maggioni, Aldo P; McMurray, John J V; Probstfield, Jeffrey L; Riddle, Matthew C; Solomon, Scott D; Tardif, Jean-Claude (2015). Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. New England Journal of Medicine, 373(23):2247-2257.

Bentley-Lewis, Rhonda; Aguilar, David; Riddle, Matthew C; Claggett, Brian; Diaz, Rafael; Dickstein, Kenneth; Gerstein, Hertzel C; Johnston, Peter; Køber, Lars V; Lawson, Francesca; Lewis, Eldrin F; Maggioni, Aldo P; McMurray, John J V; Ping, Lin; Probstfield, Jeffrey L; Solomon, Scott D; Tardif, Jean-Claude; Wu, Yujun; Pfeffer, Marc A (2015). Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo. American Heart Journal, 169(5):631-638.

Gilbert, Richard E; Mann, Johannes F E; Hanefeld, Markolf; Spinas, Giatgen; Bosch, Jackie; Yusuf, Salim; Gerstein, Hertzel C (2014). Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: Results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial. Diabetologia, 57(7):1325-1331.

Bordeleau, Louise; Yakubovich, Natalia; Dagenais, Gilles R; Rosenstock, Julio; Probstfield, Jeffrey; Chang Yu, Pan; Ryden, Lars E; Pirags, Valdis; Spinas, Giatgen A; Birkeland, Kare I; Ratner, Robert E; Marin-Neto, Jose A; Keltai, Matyas; Riddle, Matthew C; Bosch, Jackie; Yusuf, Salim; Gerstein, Hertzel C (2014). The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care, 37(5):1360-1366.

Riddle, Matthew C; Gerstein, Hertzel C; Dyal, Leanne; Hanefeld, Markolf; Johnston, Peter; Probstfield, Jeffrey; Ramachandran, Ambady; Rosenstock, Julio; Rydén, Lars E; Spinas, Giagten A (2013). Characteristics associated with maintenance of mean A1C<6.5% in people with dysglycemia in the ORIGIN trial. Diabetes Care, 36(10):2915-2922.

Gerstein, Hertzel C; Bosch, Jackie; Dagenais, Gilles R; Díaz, Rafael; Jung, Hyejung; Maggioni, Aldo P; Pogue, Janice; Probstfield, Jeffrey; Ramachandran, Ambady; Riddle, Matthew C; Rydén, Lars E; Yusuf, Salim (2012). Basal insulin and cardiovascular and other outcomes in dysglycemia. The New England Journal of Medicine, 367(4):319-328.

Bosch, Jackie; Gerstein, Hertzel C; Dagenais, Gilles R; Díaz, Rafael; Dyal, Leanne; Jung, Hyejung; Maggiono, Aldo P; Probstfield, Jeffrey; Ramachandran, Ambady; Riddle, Matthew C; Rydén, Lars E; Yusuf, Salim (2012). n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. The New England Journal of Medicine, 367(4):309-318.

This list was generated on Thu Jun 20 12:12:44 2019 CEST.